Table 2.
The prevalences of Overweight, Obesity and Abdominal obesity in three phases of TLGS.
| Age group (years) | Number | Overweight, % | Obesity, % | Abdominal obesity, % | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I | Phase II | Phase III | Phase I | Phase II | Phase III | Phase I | Phase II | Phase III | ||
| Men | ||||||||||
| 20-29 | 266 | 40.6 | 55.3 | 67.3* | 10.5 | 17.6 | 22.9* | 16.1 | 38.7 | 53.7* |
| 30-39 | 459 | 59.9 | 69.0 | 74.3* | 15.9 | 30.7 | 24.6* | 32.6 | 54.6 | 61.4* |
| 40-49 | 369 | 67.5 | 74.6 | 75.1* | 15.2 | 50.3 | 22.77* | 37.6 | 61.5 | 65.0* |
| 50-59 | 319 | 66.8 | 69.0 | 70.8 | 20.7 | 47.9 | 19.7 | 45.7 | 62.3 | 67. 7* |
| 60-69 | 328 | 66.8 | 66.5 | 66.5 | 16.8 | 41.8 | 16.5 | 48.4 | 66.4 | 69.2* |
| ≥ 70 | 94 | 52.1 | 54.2 | 48.9 | 13.8 | 19.6 | 12.8 | 35.1 | 55.3 | 57.4* |
| Total | 1835 | 60.6 | 66.9 | 70.1 | 15.8 | 37.8 | 21.1* | 36.5 | 57.2 | 63.3* |
| Women | ||||||||||
| 20-29 | 442 | 41.8 | 55.7 | 59.0* | 11.8 | 17.6 | 18.1* | 43.8 | 54.9 | 55.2* |
| 30-39 | 629 | 69.3 | 78.3 | 80.9* | 23.2 | 30.7 | 33.7* | 68.9 | 80.2 | 79.8* |
| 40-49 | 614 | 82.7 | 88.3 | 89.6* | 40.4 | 50.3 | 49.0* | 86.3 | 92.1 | 92.5* |
| 50-59 | 509 | 84.3 | 88.2 | 88.6* | 44.4 | 47.9 | 52.0* | 91.9 | 94.6 | 93.9† |
| 60-69 | 327 | 81.6 | 83.1 | 82.9 | 38.2 | 41.8 | 40.9 | 92.3 | 95.7 | 95.4† |
| ≥ 70 | 46 | 73.9 | 78.3 | 73.9 | 17.4 | 19.6 | 26.7 | 89.1 | 93.4 | 89.1 |
| Total | 2567 | 72.4 | 79.4 | 80.9* | 31.3 | 37.8 | 38.6* | 76.7 | 83.8 | 83.6* |
TLGS: Tehran Lipid and Glucose Study, Overweight: BMI = 24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively, * p < 0.001, † p < 0.01 as compared to values in Phase I